Mr. Dror Ben-Asher has been the Chief Executive Officer and Chairman of the company since 2011. He is the co-founder of the company. Prior to this, he served as a Manager at P.C.M.I. Ltd from January 2002 to November 2010. He also serves as a Director at Agrea Ltd.

Mr. Rick Scruggs has been the Chief Commercial Officer and Director of the company since 2020. Prior to this, he served as the Chief Operating Officer of the US operations and a Director of the company. Previously, Mr. Scruggs served as the Executive Vice President of Business Development at Salix. He also served as a Director Oclassen Pharmaceuticals Inc.

Mr. Razi Ingber has been the Chief Financial Officer of the company since 2023. Prior to this role, he served as the company's Vice President of Finance. Mr. Ingber also served as a Manager at PwC.

Mr. Gilead Raday has been the company's Chief Operating Officer since 2016. Prior to this, he served the Senior Vice President Corporate and Product Development and Vice President Corporate of the company. Previously, Mr. Raday also served as the Interim Chief Executive Officer of Sepal Pharma Plc. From 2004 to 2008, he was a Partner in Charles Street Securities Europe, LLP. Prior to this, Mr. Raday served on the boards of Sepal Pharma Plc, ViDAC Ltd, Morria Biopharmaceuticals Plc, Vaccine Research International Plc, TKsignal Plc and Miras Medical Imaging Plc.

Ms. Kristin Comer is the Vice President, General Counsel and Chief Compliance Officer of the company. Prior to this, she served as the Vice President and Assistant General Counsel at Syneos Health. Before that, she spent several years at GSK in various roles providing legal counsel in the areas of market access, risk management, and marketing and promotion.